nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—SLC22A6—Methazolamide—glaucoma	0.123	0.352	CbGbCtD
Tenofovir—SLC22A6—Acetazolamide—glaucoma	0.0985	0.281	CbGbCtD
Tenofovir—CYP1A2—Betaxolol—glaucoma	0.0828	0.237	CbGbCtD
Tenofovir—CYP1A2—Clonidine—glaucoma	0.0454	0.13	CbGbCtD
Tenofovir—AK2—optic choroid—glaucoma	0.0398	0.392	CbGeAlD
Tenofovir—AK2—Synthesis and interconversion of nucleotide di- and triphosphates—TXN—glaucoma	0.0163	0.11	CbGpPWpGaD
Tenofovir—ABCC10—ABC-family proteins mediated transport—PEX19—glaucoma	0.0136	0.0919	CbGpPWpGaD
Tenofovir—SLC22A8—optic choroid—glaucoma	0.0115	0.113	CbGeAlD
Tenofovir—NME2—Synthesis and interconversion of nucleotide di- and triphosphates—TXN—glaucoma	0.0113	0.076	CbGpPWpGaD
Tenofovir—NME1-NME2—eye—glaucoma	0.0106	0.104	CbGeAlD
Tenofovir—NME1—Synthesis and interconversion of nucleotide di- and triphosphates—TXN—glaucoma	0.00856	0.0576	CbGpPWpGaD
Tenofovir—AK2—eye—glaucoma	0.00801	0.079	CbGeAlD
Tenofovir—AK4—eye—glaucoma	0.00592	0.0584	CbGeAlD
Tenofovir—NME1—connective tissue—glaucoma	0.00592	0.0584	CbGeAlD
Tenofovir—AK4—retina—glaucoma	0.00587	0.0579	CbGeAlD
Tenofovir—NME2—eye—glaucoma	0.00579	0.0571	CbGeAlD
Tenofovir—NME2—retina—glaucoma	0.00574	0.0566	CbGeAlD
Tenofovir—NME1—Treprostinil—Latanoprost—glaucoma	0.00568	1	CbGdCrCtD
Tenofovir—AK2—Nucleotide metabolism—TXN—glaucoma	0.00504	0.0339	CbGpPWpGaD
Tenofovir—ABCC4—ABC-family proteins mediated transport—PEX19—glaucoma	0.00497	0.0334	CbGpPWpGaD
Tenofovir—ABCC2—ABC-family proteins mediated transport—PEX19—glaucoma	0.00419	0.0282	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.00349	0.0235	CbGpPWpGaD
Tenofovir—NME2—Nucleotide metabolism—TXN—glaucoma	0.00349	0.0235	CbGpPWpGaD
Tenofovir—Adenosine triphosphate—ABCA1—glaucoma	0.00326	1	CrCbGaD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—NTRK2—glaucoma	0.00271	0.0182	CbGpPWpGaD
Tenofovir—NME1—Nucleotide metabolism—TXN—glaucoma	0.00265	0.0178	CbGpPWpGaD
Tenofovir—SLC22A8—eye—glaucoma	0.00231	0.0228	CbGeAlD
Tenofovir—NME1—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—glaucoma	0.00202	0.0136	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—CCND2—glaucoma	0.00201	0.0135	CbGpPWpGaD
Tenofovir—ABCC4—Ectoderm Differentiation—SIX6—glaucoma	0.00199	0.0134	CbGpPWpGaD
Tenofovir—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.00174	0.0117	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—CCND2—glaucoma	0.00152	0.0102	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CA5A—glaucoma	0.00145	0.00979	CbGpPWpGaD
Tenofovir—AK2—Metabolism—NARFL—glaucoma	0.00145	0.00979	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—PEX19—glaucoma	0.00143	0.0096	CbGpPWpGaD
Tenofovir—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.0012	0.00806	CbGpPWpGaD
Tenofovir—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00109	0.00734	CbGpPWpGaD
Tenofovir—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.00107	0.00717	CbGpPWpGaD
Tenofovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.00106	0.00712	CbGpPWpGaD
Tenofovir—NME2—Metabolism—NARFL—glaucoma	0.00101	0.00679	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CA5A—glaucoma	0.00101	0.00679	CbGpPWpGaD
Tenofovir—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.001	0.00675	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.00098	0.0066	CbGpPWpGaD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000963	0.00648	CbGpPWpGaD
Tenofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000882	0.00594	CbGpPWpGaD
Tenofovir—ABCC4—Fluoropyrimidine Activity—MTHFR—glaucoma	0.000861	0.00579	CbGpPWpGaD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—MMP9—glaucoma	0.000845	0.00568	CbGpPWpGaD
Tenofovir—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000812	0.00547	CbGpPWpGaD
Tenofovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000774	0.00521	CbGpPWpGaD
Tenofovir—Dizziness—Latanoprost—glaucoma	0.000765	0.00196	CcSEcCtD
Tenofovir—NME1—Metabolism—NARFL—glaucoma	0.000764	0.00514	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CA5A—glaucoma	0.000764	0.00514	CbGpPWpGaD
Tenofovir—Vomiting—Methazolamide—glaucoma	0.00076	0.00194	CcSEcCtD
Tenofovir—Gastrointestinal pain—Apraclonidine—glaucoma	0.000756	0.00193	CcSEcCtD
Tenofovir—Rash—Methazolamide—glaucoma	0.000753	0.00193	CcSEcCtD
Tenofovir—Dermatitis—Methazolamide—glaucoma	0.000753	0.00192	CcSEcCtD
Tenofovir—Nausea—Carbachol—glaucoma	0.000752	0.00192	CcSEcCtD
Tenofovir—Sweating—Betaxolol—glaucoma	0.000749	0.00191	CcSEcCtD
Tenofovir—Headache—Methazolamide—glaucoma	0.000749	0.00191	CcSEcCtD
Tenofovir—Myalgia—Pilocarpine—glaucoma	0.000747	0.00191	CcSEcCtD
Tenofovir—Arthralgia—Pilocarpine—glaucoma	0.000747	0.00191	CcSEcCtD
Tenofovir—Chest pain—Pilocarpine—glaucoma	0.000747	0.00191	CcSEcCtD
Tenofovir—Anxiety—Pilocarpine—glaucoma	0.000745	0.0019	CcSEcCtD
Tenofovir—Nausea—Levobunolol—glaucoma	0.000741	0.00189	CcSEcCtD
Tenofovir—Nervous system disorder—Travoprost—glaucoma	0.00074	0.00189	CcSEcCtD
Tenofovir—Nasopharyngitis—Timolol—glaucoma	0.00074	0.00189	CcSEcCtD
Tenofovir—Skin disorder—Travoprost—glaucoma	0.000733	0.00187	CcSEcCtD
Tenofovir—Hyperhidrosis—Dorzolamide—glaucoma	0.000733	0.00187	CcSEcCtD
Tenofovir—Sinusitis—Betaxolol—glaucoma	0.000733	0.00187	CcSEcCtD
Tenofovir—Abdominal pain—Apraclonidine—glaucoma	0.000731	0.00187	CcSEcCtD
Tenofovir—Nervous system disorder—Brinzolamide—glaucoma	0.000731	0.00187	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—SLC6A13—glaucoma	0.000731	0.00492	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000731	0.00492	CbGpPWpGaD
Tenofovir—Rash—Latanoprost—glaucoma	0.000729	0.00186	CcSEcCtD
Tenofovir—Dermatitis—Latanoprost—glaucoma	0.000729	0.00186	CcSEcCtD
Tenofovir—Dyspepsia—Acetazolamide—glaucoma	0.000728	0.00186	CcSEcCtD
Tenofovir—Mediastinal disorder—Clonidine—glaucoma	0.000726	0.00186	CcSEcCtD
Tenofovir—Headache—Latanoprost—glaucoma	0.000725	0.00185	CcSEcCtD
Tenofovir—Skin disorder—Brinzolamide—glaucoma	0.000724	0.00185	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000723	0.00185	CcSEcCtD
Tenofovir—Anorexia—Dorzolamide—glaucoma	0.000723	0.00185	CcSEcCtD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.00072	0.00485	CbGpPWpGaD
Tenofovir—Decreased appetite—Acetazolamide—glaucoma	0.000719	0.00184	CcSEcCtD
Tenofovir—Insomnia—Brimonidine—glaucoma	0.000718	0.00184	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000714	0.00183	CcSEcCtD
Tenofovir—Fatigue—Acetazolamide—glaucoma	0.000713	0.00182	CcSEcCtD
Tenofovir—AK2—Metabolism—CA1—glaucoma	0.00071	0.00478	CbGpPWpGaD
Tenofovir—Nausea—Methazolamide—glaucoma	0.00071	0.00181	CcSEcCtD
Tenofovir—Dyspnoea—Brimonidine—glaucoma	0.000708	0.00181	CcSEcCtD
Tenofovir—ABCC4—Platelet degranulation—TGFB2—glaucoma	0.000706	0.00475	CbGpPWpGaD
Tenofovir—Mental disorder—Clonidine—glaucoma	0.000705	0.0018	CcSEcCtD
Tenofovir—Dyspepsia—Brimonidine—glaucoma	0.000699	0.00179	CcSEcCtD
Tenofovir—Hyperhidrosis—Pilocarpine—glaucoma	0.000693	0.00177	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000691	0.00177	CcSEcCtD
Tenofovir—AK2—Metabolism—CTSA—glaucoma	0.000688	0.00463	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Travoprost—glaucoma	0.000688	0.00176	CcSEcCtD
Tenofovir—Insomnia—Dorzolamide—glaucoma	0.000686	0.00175	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Brimonidine—glaucoma	0.000685	0.00175	CcSEcCtD
Tenofovir—Fatigue—Brimonidine—glaucoma	0.000684	0.00175	CcSEcCtD
Tenofovir—Anorexia—Pilocarpine—glaucoma	0.000683	0.00175	CcSEcCtD
Tenofovir—Hypersensitivity—Apraclonidine—glaucoma	0.000681	0.00174	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000679	0.00174	CcSEcCtD
Tenofovir—Pain—Brimonidine—glaucoma	0.000679	0.00174	CcSEcCtD
Tenofovir—Dyspnoea—Dorzolamide—glaucoma	0.000676	0.00173	CcSEcCtD
Tenofovir—Insomnia—Brinzolamide—glaucoma	0.000674	0.00172	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000673	0.00453	CbGpPWpGaD
Tenofovir—Dyspnoea—Travoprost—glaucoma	0.000673	0.00172	CcSEcCtD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB2—glaucoma	0.000672	0.00452	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000669	0.0045	CbGpPWpGaD
Tenofovir—Dyspepsia—Dorzolamide—glaucoma	0.000667	0.00171	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Timolol—glaucoma	0.000665	0.0017	CcSEcCtD
Tenofovir—Dyspnoea—Brinzolamide—glaucoma	0.000664	0.0017	CcSEcCtD
Tenofovir—Dyspepsia—Travoprost—glaucoma	0.000664	0.0017	CcSEcCtD
Tenofovir—Asthenia—Apraclonidine—glaucoma	0.000663	0.0017	CcSEcCtD
Tenofovir—Decreased appetite—Dorzolamide—glaucoma	0.000659	0.00169	CcSEcCtD
Tenofovir—Dyspepsia—Brinzolamide—glaucoma	0.000656	0.00168	CcSEcCtD
Tenofovir—Pruritus—Apraclonidine—glaucoma	0.000654	0.00167	CcSEcCtD
Tenofovir—Body temperature increased—Acetazolamide—glaucoma	0.000654	0.00167	CcSEcCtD
Tenofovir—Fatigue—Dorzolamide—glaucoma	0.000654	0.00167	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000653	0.00167	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Travoprost—glaucoma	0.000652	0.00167	CcSEcCtD
Tenofovir—Fatigue—Travoprost—glaucoma	0.000651	0.00166	CcSEcCtD
Tenofovir—AK2—Metabolism—CA2—glaucoma	0.00065	0.00437	CbGpPWpGaD
Tenofovir—Pain—Dorzolamide—glaucoma	0.000648	0.00166	CcSEcCtD
Tenofovir—Insomnia—Pilocarpine—glaucoma	0.000648	0.00166	CcSEcCtD
Tenofovir—Decreased appetite—Brinzolamide—glaucoma	0.000648	0.00166	CcSEcCtD
Tenofovir—Weight decreased—Timolol—glaucoma	0.000647	0.00166	CcSEcCtD
Tenofovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000646	0.00435	CbGpPWpGaD
Tenofovir—Pain—Travoprost—glaucoma	0.000645	0.00165	CcSEcCtD
Tenofovir—Hyperglycaemia—Timolol—glaucoma	0.000645	0.00165	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000643	0.00165	CcSEcCtD
Tenofovir—Asthenia—Bimatoprost—glaucoma	0.000643	0.00164	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000643	0.00433	CbGpPWpGaD
Tenofovir—Fatigue—Brinzolamide—glaucoma	0.000643	0.00164	CcSEcCtD
Tenofovir—Angioedema—Clonidine—glaucoma	0.00064	0.00164	CcSEcCtD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—MMP9—glaucoma	0.00064	0.00431	CbGpPWpGaD
Tenofovir—Dyspnoea—Pilocarpine—glaucoma	0.000639	0.00163	CcSEcCtD
Tenofovir—Pain—Brinzolamide—glaucoma	0.000637	0.00163	CcSEcCtD
Tenofovir—Depression—Timolol—glaucoma	0.000636	0.00163	CcSEcCtD
Tenofovir—Pruritus—Bimatoprost—glaucoma	0.000634	0.00162	CcSEcCtD
Tenofovir—Immune system disorder—Betaxolol—glaucoma	0.000633	0.00162	CcSEcCtD
Tenofovir—Diarrhoea—Apraclonidine—glaucoma	0.000633	0.00162	CcSEcCtD
Tenofovir—Mediastinal disorder—Betaxolol—glaucoma	0.000632	0.00162	CcSEcCtD
Tenofovir—Dyspepsia—Pilocarpine—glaucoma	0.000631	0.00161	CcSEcCtD
Tenofovir—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000626	0.00421	CbGpPWpGaD
Tenofovir—Decreased appetite—Pilocarpine—glaucoma	0.000623	0.00159	CcSEcCtD
Tenofovir—Gastrointestinal pain—Dorzolamide—glaucoma	0.00062	0.00159	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000618	0.00158	CcSEcCtD
Tenofovir—Gastrointestinal pain—Travoprost—glaucoma	0.000617	0.00158	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—SLC6A13—glaucoma	0.000616	0.00415	CbGpPWpGaD
Tenofovir—Mental disorder—Betaxolol—glaucoma	0.000614	0.00157	CcSEcCtD
Tenofovir—Pain—Pilocarpine—glaucoma	0.000613	0.00157	CcSEcCtD
Tenofovir—Sweating—Timolol—glaucoma	0.000612	0.00156	CcSEcCtD
Tenofovir—Dizziness—Apraclonidine—glaucoma	0.000611	0.00156	CcSEcCtD
Tenofovir—Malnutrition—Betaxolol—glaucoma	0.00061	0.00156	CcSEcCtD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000601	0.00404	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—TXN—glaucoma	0.0006	0.00404	CbGpPWpGaD
Tenofovir—Abdominal pain—Dorzolamide—glaucoma	0.000599	0.00153	CcSEcCtD
Tenofovir—Body temperature increased—Dorzolamide—glaucoma	0.000599	0.00153	CcSEcCtD
Tenofovir—Sinusitis—Timolol—glaucoma	0.000598	0.00153	CcSEcCtD
Tenofovir—Arthralgia—Clonidine—glaucoma	0.000597	0.00153	CcSEcCtD
Tenofovir—Chest pain—Clonidine—glaucoma	0.000597	0.00153	CcSEcCtD
Tenofovir—Abdominal pain—Travoprost—glaucoma	0.000597	0.00153	CcSEcCtD
Tenofovir—Anxiety—Clonidine—glaucoma	0.000595	0.00152	CcSEcCtD
Tenofovir—Asthenia—Acetazolamide—glaucoma	0.000593	0.00152	CcSEcCtD
Tenofovir—Dizziness—Bimatoprost—glaucoma	0.000593	0.00152	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000593	0.00152	CcSEcCtD
Tenofovir—Vomiting—Apraclonidine—glaucoma	0.000588	0.0015	CcSEcCtD
Tenofovir—Gastrointestinal pain—Pilocarpine—glaucoma	0.000586	0.0015	CcSEcCtD
Tenofovir—Hypersensitivity—Brimonidine—glaucoma	0.000585	0.0015	CcSEcCtD
Tenofovir—Dermatitis—Apraclonidine—glaucoma	0.000582	0.00149	CcSEcCtD
Tenofovir—Headache—Apraclonidine—glaucoma	0.000579	0.00148	CcSEcCtD
Tenofovir—NME2—Validated targets of C-MYC transcriptional activation—TP53—glaucoma	0.000573	0.00386	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000573	0.00385	CbGpPWpGaD
Tenofovir—Asthenia—Brimonidine—glaucoma	0.00057	0.00146	CcSEcCtD
Tenofovir—Abdominal pain—Pilocarpine—glaucoma	0.000566	0.00145	CcSEcCtD
Tenofovir—Body temperature increased—Pilocarpine—glaucoma	0.000566	0.00145	CcSEcCtD
Tenofovir—Diarrhoea—Acetazolamide—glaucoma	0.000566	0.00145	CcSEcCtD
Tenofovir—Rash—Bimatoprost—glaucoma	0.000565	0.00145	CcSEcCtD
Tenofovir—Dermatitis—Bimatoprost—glaucoma	0.000565	0.00144	CcSEcCtD
Tenofovir—Connective tissue disorder—Timolol—glaucoma	0.000563	0.00144	CcSEcCtD
Tenofovir—Pruritus—Brimonidine—glaucoma	0.000562	0.00144	CcSEcCtD
Tenofovir—Headache—Bimatoprost—glaucoma	0.000562	0.00144	CcSEcCtD
Tenofovir—Nervous system disorder—Clonidine—glaucoma	0.000561	0.00143	CcSEcCtD
Tenofovir—Hypersensitivity—Dorzolamide—glaucoma	0.000559	0.00143	CcSEcCtD
Tenofovir—Hypersensitivity—Travoprost—glaucoma	0.000556	0.00142	CcSEcCtD
Tenofovir—Skin disorder—Clonidine—glaucoma	0.000556	0.00142	CcSEcCtD
Tenofovir—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000554	0.00373	CbGpPWpGaD
Tenofovir—Hyperhidrosis—Clonidine—glaucoma	0.000553	0.00141	CcSEcCtD
Tenofovir—Nausea—Apraclonidine—glaucoma	0.000549	0.0014	CcSEcCtD
Tenofovir—Hypersensitivity—Brinzolamide—glaucoma	0.000549	0.0014	CcSEcCtD
Tenofovir—Dizziness—Acetazolamide—glaucoma	0.000547	0.0014	CcSEcCtD
Tenofovir—Anorexia—Clonidine—glaucoma	0.000545	0.00139	CcSEcCtD
Tenofovir—Asthenia—Dorzolamide—glaucoma	0.000544	0.00139	CcSEcCtD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—PEX19—glaucoma	0.000542	0.00365	CbGpPWpGaD
Tenofovir—Asthenia—Travoprost—glaucoma	0.000542	0.00138	CcSEcCtD
Tenofovir—Pruritus—Dorzolamide—glaucoma	0.000536	0.00137	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—SLC6A1—glaucoma	0.000535	0.0036	CbGpPWpGaD
Tenofovir—Asthenia—Brinzolamide—glaucoma	0.000535	0.00137	CcSEcCtD
Tenofovir—ABCC4—Platelet degranulation—SOD1—glaucoma	0.000535	0.0036	CbGpPWpGaD
Tenofovir—Pruritus—Travoprost—glaucoma	0.000534	0.00137	CcSEcCtD
Tenofovir—Nausea—Bimatoprost—glaucoma	0.000532	0.00136	CcSEcCtD
Tenofovir—Hypersensitivity—Pilocarpine—glaucoma	0.000528	0.00135	CcSEcCtD
Tenofovir—Pruritus—Brinzolamide—glaucoma	0.000527	0.00135	CcSEcCtD
Tenofovir—Vomiting—Acetazolamide—glaucoma	0.000526	0.00134	CcSEcCtD
Tenofovir—Dizziness—Brimonidine—glaucoma	0.000525	0.00134	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Clonidine—glaucoma	0.000521	0.00133	CcSEcCtD
Tenofovir—Myalgia—Betaxolol—glaucoma	0.00052	0.00133	CcSEcCtD
Tenofovir—Chest pain—Betaxolol—glaucoma	0.00052	0.00133	CcSEcCtD
Tenofovir—Arthralgia—Betaxolol—glaucoma	0.00052	0.00133	CcSEcCtD
Tenofovir—ABCC4—Transmembrane transport of small molecules—PEX19—glaucoma	0.000519	0.0035	CbGpPWpGaD
Tenofovir—Diarrhoea—Dorzolamide—glaucoma	0.000519	0.00133	CcSEcCtD
Tenofovir—Headache—Acetazolamide—glaucoma	0.000518	0.00132	CcSEcCtD
Tenofovir—Anxiety—Betaxolol—glaucoma	0.000518	0.00132	CcSEcCtD
Tenofovir—Insomnia—Clonidine—glaucoma	0.000517	0.00132	CcSEcCtD
Tenofovir—Immune system disorder—Timolol—glaucoma	0.000517	0.00132	CcSEcCtD
Tenofovir—Diarrhoea—Travoprost—glaucoma	0.000516	0.00132	CcSEcCtD
Tenofovir—Mediastinal disorder—Timolol—glaucoma	0.000516	0.00132	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000516	0.00132	CcSEcCtD
Tenofovir—Asthenia—Pilocarpine—glaucoma	0.000514	0.00131	CcSEcCtD
Tenofovir—Dyspnoea—Clonidine—glaucoma	0.00051	0.0013	CcSEcCtD
Tenofovir—Diarrhoea—Brinzolamide—glaucoma	0.00051	0.0013	CcSEcCtD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—glaucoma	0.000509	0.00343	CbGpPWpGaD
Tenofovir—Pruritus—Pilocarpine—glaucoma	0.000507	0.0013	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—TXN—glaucoma	0.000506	0.00341	CbGpPWpGaD
Tenofovir—Mental disorder—Timolol—glaucoma	0.000502	0.00128	CcSEcCtD
Tenofovir—Dizziness—Dorzolamide—glaucoma	0.000501	0.00128	CcSEcCtD
Tenofovir—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000501	0.00337	CbGpPWpGaD
Tenofovir—Rash—Brimonidine—glaucoma	0.000501	0.00128	CcSEcCtD
Tenofovir—Dermatitis—Brimonidine—glaucoma	0.0005	0.00128	CcSEcCtD
Tenofovir—Dizziness—Travoprost—glaucoma	0.000499	0.00128	CcSEcCtD
Tenofovir—Malnutrition—Timolol—glaucoma	0.000499	0.00127	CcSEcCtD
Tenofovir—Headache—Brimonidine—glaucoma	0.000497	0.00127	CcSEcCtD
Tenofovir—Decreased appetite—Clonidine—glaucoma	0.000497	0.00127	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Clonidine—glaucoma	0.000494	0.00126	CcSEcCtD
Tenofovir—Fatigue—Clonidine—glaucoma	0.000493	0.00126	CcSEcCtD
Tenofovir—Dizziness—Brinzolamide—glaucoma	0.000493	0.00126	CcSEcCtD
Tenofovir—NME2—Metabolism—CA1—glaucoma	0.000492	0.00331	CbGpPWpGaD
Tenofovir—Nausea—Acetazolamide—glaucoma	0.000491	0.00126	CcSEcCtD
Tenofovir—Diarrhoea—Pilocarpine—glaucoma	0.00049	0.00125	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.00049	0.0033	CbGpPWpGaD
Tenofovir—Pain—Clonidine—glaucoma	0.000489	0.00125	CcSEcCtD
Tenofovir—Nervous system disorder—Betaxolol—glaucoma	0.000488	0.00125	CcSEcCtD
Tenofovir—Skin disorder—Betaxolol—glaucoma	0.000484	0.00124	CcSEcCtD
Tenofovir—Vomiting—Dorzolamide—glaucoma	0.000482	0.00123	CcSEcCtD
Tenofovir—Hyperhidrosis—Betaxolol—glaucoma	0.000481	0.00123	CcSEcCtD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.00048	0.00323	CbGpPWpGaD
Tenofovir—Rash—Dorzolamide—glaucoma	0.000478	0.00122	CcSEcCtD
Tenofovir—Dermatitis—Dorzolamide—glaucoma	0.000478	0.00122	CcSEcCtD
Tenofovir—NME2—Metabolism—CTSA—glaucoma	0.000477	0.00321	CbGpPWpGaD
Tenofovir—Rash—Travoprost—glaucoma	0.000476	0.00122	CcSEcCtD
Tenofovir—Dermatitis—Travoprost—glaucoma	0.000475	0.00122	CcSEcCtD
Tenofovir—Headache—Dorzolamide—glaucoma	0.000475	0.00121	CcSEcCtD
Tenofovir—Anorexia—Betaxolol—glaucoma	0.000475	0.00121	CcSEcCtD
Tenofovir—Vomiting—Brinzolamide—glaucoma	0.000474	0.00121	CcSEcCtD
Tenofovir—Dizziness—Pilocarpine—glaucoma	0.000474	0.00121	CcSEcCtD
Tenofovir—Headache—Travoprost—glaucoma	0.000473	0.00121	CcSEcCtD
Tenofovir—Nausea—Brimonidine—glaucoma	0.000472	0.00121	CcSEcCtD
Tenofovir—ABCC10—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.00047	0.00317	CbGpPWpGaD
Tenofovir—Rash—Brinzolamide—glaucoma	0.00047	0.0012	CcSEcCtD
Tenofovir—Dermatitis—Brinzolamide—glaucoma	0.000469	0.0012	CcSEcCtD
Tenofovir—Gastrointestinal pain—Clonidine—glaucoma	0.000468	0.0012	CcSEcCtD
Tenofovir—Headache—Brinzolamide—glaucoma	0.000467	0.00119	CcSEcCtD
Tenofovir—ABCC4—Ectoderm Differentiation—PAX6—glaucoma	0.000463	0.00312	CbGpPWpGaD
Tenofovir—AK2—Metabolism—TXN—glaucoma	0.000458	0.00308	CbGpPWpGaD
Tenofovir—Angioedema—Timolol—glaucoma	0.000456	0.00116	CcSEcCtD
Tenofovir—Vomiting—Pilocarpine—glaucoma	0.000455	0.00116	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000454	0.00116	CcSEcCtD
Tenofovir—Abdominal pain—Clonidine—glaucoma	0.000452	0.00116	CcSEcCtD
Tenofovir—Body temperature increased—Clonidine—glaucoma	0.000452	0.00116	CcSEcCtD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—PEX19—glaucoma	0.000452	0.00304	CbGpPWpGaD
Tenofovir—Rash—Pilocarpine—glaucoma	0.000452	0.00115	CcSEcCtD
Tenofovir—Dermatitis—Pilocarpine—glaucoma	0.000451	0.00115	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—SLC6A1—glaucoma	0.000451	0.00304	CbGpPWpGaD
Tenofovir—Insomnia—Betaxolol—glaucoma	0.00045	0.00115	CcSEcCtD
Tenofovir—NME2—Metabolism—CA2—glaucoma	0.00045	0.00303	CbGpPWpGaD
Tenofovir—Nausea—Dorzolamide—glaucoma	0.00045	0.00115	CcSEcCtD
Tenofovir—Headache—Pilocarpine—glaucoma	0.000449	0.00115	CcSEcCtD
Tenofovir—Nausea—Travoprost—glaucoma	0.000448	0.00115	CcSEcCtD
Tenofovir—Dyspnoea—Betaxolol—glaucoma	0.000444	0.00114	CcSEcCtD
Tenofovir—Nausea—Brinzolamide—glaucoma	0.000443	0.00113	CcSEcCtD
Tenofovir—Dyspepsia—Betaxolol—glaucoma	0.000438	0.00112	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000438	0.00295	CbGpPWpGaD
Tenofovir—ABCC4—NRF2 pathway—TGFB2—glaucoma	0.000436	0.00293	CbGpPWpGaD
Tenofovir—NME1—Validated targets of C-MYC transcriptional activation—TP53—glaucoma	0.000434	0.00292	CbGpPWpGaD
Tenofovir—Decreased appetite—Betaxolol—glaucoma	0.000433	0.00111	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Betaxolol—glaucoma	0.00043	0.0011	CcSEcCtD
Tenofovir—Fatigue—Betaxolol—glaucoma	0.000429	0.0011	CcSEcCtD
Tenofovir—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000428	0.00288	CbGpPWpGaD
Tenofovir—Pain—Betaxolol—glaucoma	0.000426	0.00109	CcSEcCtD
Tenofovir—Nausea—Pilocarpine—glaucoma	0.000425	0.00109	CcSEcCtD
Tenofovir—Chest pain—Timolol—glaucoma	0.000424	0.00109	CcSEcCtD
Tenofovir—Myalgia—Timolol—glaucoma	0.000424	0.00109	CcSEcCtD
Tenofovir—Arthralgia—Timolol—glaucoma	0.000424	0.00109	CcSEcCtD
Tenofovir—Anxiety—Timolol—glaucoma	0.000423	0.00108	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000421	0.00108	CcSEcCtD
Tenofovir—Hypersensitivity—Clonidine—glaucoma	0.000421	0.00108	CcSEcCtD
Tenofovir—Asthenia—Clonidine—glaucoma	0.00041	0.00105	CcSEcCtD
Tenofovir—Pruritus—Clonidine—glaucoma	0.000405	0.00103	CcSEcCtD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000401	0.0027	CbGpPWpGaD
Tenofovir—Nervous system disorder—Timolol—glaucoma	0.000399	0.00102	CcSEcCtD
Tenofovir—Skin disorder—Timolol—glaucoma	0.000395	0.00101	CcSEcCtD
Tenofovir—Body temperature increased—Betaxolol—glaucoma	0.000394	0.00101	CcSEcCtD
Tenofovir—Hyperhidrosis—Timolol—glaucoma	0.000393	0.00101	CcSEcCtD
Tenofovir—Diarrhoea—Clonidine—glaucoma	0.000391	0.001	CcSEcCtD
Tenofovir—Anorexia—Timolol—glaucoma	0.000388	0.000992	CcSEcCtD
Tenofovir—Dizziness—Clonidine—glaucoma	0.000378	0.000967	CcSEcCtD
Tenofovir—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000376	0.00253	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CA1—glaucoma	0.000373	0.00251	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—FN1—glaucoma	0.000372	0.0025	CbGpPWpGaD
Tenofovir—Musculoskeletal discomfort—Timolol—glaucoma	0.000371	0.000948	CcSEcCtD
Tenofovir—Insomnia—Timolol—glaucoma	0.000368	0.000941	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—TGFB2—glaucoma	0.000368	0.00247	CbGpPWpGaD
Tenofovir—Hypersensitivity—Betaxolol—glaucoma	0.000367	0.000938	CcSEcCtD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000366	0.00246	CbGpPWpGaD
Tenofovir—Vomiting—Clonidine—glaucoma	0.000364	0.00093	CcSEcCtD
Tenofovir—Dyspnoea—Timolol—glaucoma	0.000363	0.000928	CcSEcCtD
Tenofovir—NME1—Metabolism—CTSA—glaucoma	0.000361	0.00243	CbGpPWpGaD
Tenofovir—Rash—Clonidine—glaucoma	0.000361	0.000922	CcSEcCtD
Tenofovir—Dermatitis—Clonidine—glaucoma	0.00036	0.000921	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.00036	0.00242	CbGpPWpGaD
Tenofovir—Headache—Clonidine—glaucoma	0.000358	0.000916	CcSEcCtD
Tenofovir—Dyspepsia—Timolol—glaucoma	0.000358	0.000916	CcSEcCtD
Tenofovir—Asthenia—Betaxolol—glaucoma	0.000357	0.000914	CcSEcCtD
Tenofovir—AK2—Metabolism—GSTT1—glaucoma	0.000355	0.00239	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	0.000354	0.00239	CbGpPWpGaD
Tenofovir—Decreased appetite—Timolol—glaucoma	0.000354	0.000904	CcSEcCtD
Tenofovir—Pruritus—Betaxolol—glaucoma	0.000352	0.000901	CcSEcCtD
Tenofovir—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000352	0.00237	CbGpPWpGaD
Tenofovir—Gastrointestinal disorder—Timolol—glaucoma	0.000351	0.000898	CcSEcCtD
Tenofovir—Fatigue—Timolol—glaucoma	0.000351	0.000897	CcSEcCtD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000351	0.00236	CbGpPWpGaD
Tenofovir—Pain—Timolol—glaucoma	0.000348	0.00089	CcSEcCtD
Tenofovir—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000346	0.00233	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CA2—glaucoma	0.000341	0.0023	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000341	0.0023	CbGpPWpGaD
Tenofovir—Diarrhoea—Betaxolol—glaucoma	0.000341	0.000871	CcSEcCtD
Tenofovir—Nausea—Clonidine—glaucoma	0.00034	0.000869	CcSEcCtD
Tenofovir—Gastrointestinal pain—Timolol—glaucoma	0.000333	0.000851	CcSEcCtD
Tenofovir—Dizziness—Betaxolol—glaucoma	0.000329	0.000842	CcSEcCtD
Tenofovir—ABCC4—Fluoropyrimidine Activity—TP53—glaucoma	0.000327	0.0022	CbGpPWpGaD
Tenofovir—Body temperature increased—Timolol—glaucoma	0.000322	0.000822	CcSEcCtD
Tenofovir—Abdominal pain—Timolol—glaucoma	0.000322	0.000822	CcSEcCtD
Tenofovir—NME2—Metabolism—TXN—glaucoma	0.000317	0.00214	CbGpPWpGaD
Tenofovir—Vomiting—Betaxolol—glaucoma	0.000317	0.00081	CcSEcCtD
Tenofovir—Rash—Betaxolol—glaucoma	0.000314	0.000803	CcSEcCtD
Tenofovir—Dermatitis—Betaxolol—glaucoma	0.000314	0.000802	CcSEcCtD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—TGFB2—glaucoma	0.000313	0.00211	CbGpPWpGaD
Tenofovir—Headache—Betaxolol—glaucoma	0.000312	0.000798	CcSEcCtD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000305	0.00206	CbGpPWpGaD
Tenofovir—Hypersensitivity—Timolol—glaucoma	0.0003	0.000767	CcSEcCtD
Tenofovir—ABCC4—NRF2 pathway—GSTM1—glaucoma	0.000296	0.00199	CbGpPWpGaD
Tenofovir—Nausea—Betaxolol—glaucoma	0.000296	0.000756	CcSEcCtD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000296	0.00199	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000296	0.00199	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000296	0.00199	CbGpPWpGaD
Tenofovir—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000296	0.00199	CbGpPWpGaD
Tenofovir—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000293	0.00198	CbGpPWpGaD
Tenofovir—Asthenia—Timolol—glaucoma	0.000292	0.000746	CcSEcCtD
Tenofovir—Pruritus—Timolol—glaucoma	0.000288	0.000736	CcSEcCtD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000284	0.00191	CbGpPWpGaD
Tenofovir—AK2—Metabolism—ABCA1—glaucoma	0.000283	0.0019	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CYP1B1—glaucoma	0.000283	0.0019	CbGpPWpGaD
Tenofovir—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000281	0.00189	CbGpPWpGaD
Tenofovir—Diarrhoea—Timolol—glaucoma	0.000278	0.000712	CcSEcCtD
Tenofovir—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000277	0.00186	CbGpPWpGaD
Tenofovir—Dizziness—Timolol—glaucoma	0.000269	0.000688	CcSEcCtD
Tenofovir—Vomiting—Timolol—glaucoma	0.000259	0.000661	CcSEcCtD
Tenofovir—Rash—Timolol—glaucoma	0.000257	0.000656	CcSEcCtD
Tenofovir—Dermatitis—Timolol—glaucoma	0.000256	0.000655	CcSEcCtD
Tenofovir—Headache—Timolol—glaucoma	0.000255	0.000652	CcSEcCtD
Tenofovir—ABCC2—NRF2 pathway—GSTM1—glaucoma	0.00025	0.00168	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTT1—glaucoma	0.000246	0.00166	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000244	0.00164	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000243	0.00164	CbGpPWpGaD
Tenofovir—Nausea—Timolol—glaucoma	0.000242	0.000618	CcSEcCtD
Tenofovir—NME1—Metabolism—TXN—glaucoma	0.00024	0.00162	CbGpPWpGaD
Tenofovir—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000239	0.00161	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—SOD1—glaucoma	0.000237	0.0016	CbGpPWpGaD
Tenofovir—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000236	0.00159	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000234	0.00158	CbGpPWpGaD
Tenofovir—AK2—Metabolism—GSTM1—glaucoma	0.000226	0.00152	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000221	0.00149	CbGpPWpGaD
Tenofovir—NME1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000214	0.00144	CbGpPWpGaD
Tenofovir—ABCC4—Platelet degranulation—VEGFA—glaucoma	0.000213	0.00143	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000204	0.00137	CbGpPWpGaD
Tenofovir—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	0.000203	0.00137	CbGpPWpGaD
Tenofovir—AK2—Metabolism—MTHFR—glaucoma	0.0002	0.00134	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000197	0.00133	CbGpPWpGaD
Tenofovir—NME2—Metabolism—ABCA1—glaucoma	0.000196	0.00132	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CYP1B1—glaucoma	0.000196	0.00132	CbGpPWpGaD
Tenofovir—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000194	0.0013	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTT1—glaucoma	0.000186	0.00126	CbGpPWpGaD
Tenofovir—AK2—Metabolism—APOE—glaucoma	0.000186	0.00125	CbGpPWpGaD
Tenofovir—AK2—Metabolism—CAV1—glaucoma	0.000184	0.00124	CbGpPWpGaD
Tenofovir—SLC22A8—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000179	0.0012	CbGpPWpGaD
Tenofovir—ABCC4—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000171	0.00115	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—FN1—glaucoma	0.000165	0.00111	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TGFB2—glaucoma	0.000161	0.00109	CbGpPWpGaD
Tenofovir—NME2—Metabolism—GSTM1—glaucoma	0.000157	0.00105	CbGpPWpGaD
Tenofovir—SLC22A6—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000149	0.001	CbGpPWpGaD
Tenofovir—NME1—Metabolism—ABCA1—glaucoma	0.000149	0.001	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CYP1B1—glaucoma	0.000149	0.001	CbGpPWpGaD
Tenofovir—ABCC2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000144	0.000972	CbGpPWpGaD
Tenofovir—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.000141	0.000947	CbGpPWpGaD
Tenofovir—AK2—Metabolism—NOS3—glaucoma	0.000139	0.000938	CbGpPWpGaD
Tenofovir—NME2—Metabolism—MTHFR—glaucoma	0.000139	0.000932	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000133	0.000897	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000129	0.000869	CbGpPWpGaD
Tenofovir—NME2—Metabolism—APOE—glaucoma	0.000129	0.000868	CbGpPWpGaD
Tenofovir—NME2—Metabolism—CAV1—glaucoma	0.000128	0.00086	CbGpPWpGaD
Tenofovir—AK2—Metabolism—PTGS2—glaucoma	0.000127	0.000858	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000126	0.000849	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000126	0.000849	CbGpPWpGaD
Tenofovir—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	0.000125	0.000839	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—SOD1—glaucoma	0.000122	0.000823	CbGpPWpGaD
Tenofovir—NME1—Metabolism—GSTM1—glaucoma	0.000119	0.000799	CbGpPWpGaD
Tenofovir—NME1—Metabolism—MTHFR—glaucoma	0.000105	0.000707	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000105	0.000706	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—CYP1B1—glaucoma	0.000103	0.000693	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	0.000102	0.000683	CbGpPWpGaD
Tenofovir—NME1—Metabolism—APOE—glaucoma	9.77e-05	0.000658	CbGpPWpGaD
Tenofovir—NME1—Metabolism—CAV1—glaucoma	9.68e-05	0.000652	CbGpPWpGaD
Tenofovir—NME2—Metabolism—NOS3—glaucoma	9.66e-05	0.00065	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	9.61e-05	0.000647	CbGpPWpGaD
Tenofovir—ABCC4—Platelet activation, signaling and aggregation—VEGFA—glaucoma	9.45e-05	0.000636	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—MMP1—glaucoma	9.32e-05	0.000628	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NARFL—glaucoma	9.05e-05	0.000609	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CA5A—glaucoma	9.05e-05	0.000609	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	8.99e-05	0.000605	CbGpPWpGaD
Tenofovir—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	8.99e-05	0.000605	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—CAV1—glaucoma	8.94e-05	0.000602	CbGpPWpGaD
Tenofovir—NME2—Metabolism—PTGS2—glaucoma	8.84e-05	0.000595	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—FN1—glaucoma	8.51e-05	0.000573	CbGpPWpGaD
Tenofovir—CYP1A2—Biological oxidations—GSTM1—glaucoma	8.23e-05	0.000554	CbGpPWpGaD
Tenofovir—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	8.11e-05	0.000546	CbGpPWpGaD
Tenofovir—NME1—Metabolism—NOS3—glaucoma	7.32e-05	0.000493	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—NOS3—glaucoma	6.76e-05	0.000455	CbGpPWpGaD
Tenofovir—NME1—Metabolism—PTGS2—glaucoma	6.7e-05	0.000451	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—VEGFA—glaucoma	4.87e-05	0.000328	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CA1—glaucoma	4.42e-05	0.000298	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CTSA—glaucoma	4.28e-05	0.000288	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CA2—glaucoma	4.04e-05	0.000272	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	3.95e-05	0.000266	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	3.95e-05	0.000266	CbGpPWpGaD
Tenofovir—ABCC4—Hemostasis—TP53—glaucoma	3.68e-05	0.000248	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—TXN—glaucoma	2.85e-05	0.000192	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	2.6e-05	0.000175	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	2.58e-05	0.000173	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTT1—glaucoma	2.21e-05	0.000149	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.78e-05	0.00012	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—ABCA1—glaucoma	1.76e-05	0.000118	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CYP1B1—glaucoma	1.76e-05	0.000118	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—GSTM1—glaucoma	1.41e-05	9.47e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—MTHFR—glaucoma	1.24e-05	8.37e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—APOE—glaucoma	1.16e-05	7.79e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—CAV1—glaucoma	1.15e-05	7.72e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—NOS3—glaucoma	8.67e-06	5.84e-05	CbGpPWpGaD
Tenofovir—CYP1A2—Metabolism—PTGS2—glaucoma	7.93e-06	5.34e-05	CbGpPWpGaD
